ICD-10 Chapter IV: Endocrine, nutritional and metabolic diseases

From Wikipedia, the free encyclopedia
International Statistical Classification of Diseases and Related Health Problems 10th Revision
Chapter Blocks Title
I A00–B99 Certain infectious and parasitic diseases
II C00–D48 Neoplasms
III D50–D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
IV E00–E90 Endocrine, nutritional and metabolic diseases
V F00–F99 Mental and behavioural disorders
VI G00–G99 Diseases of the nervous system
VII H00–H59 Diseases of the eye and adnexa
VIII H60–H95 Diseases of the ear and mastoid process
IX I00–I99 Diseases of the circulatory system
X J00–J99 Diseases of the respiratory system
XI K00–K93 Diseases of the digestive system
XII L00–L99 Diseases of the skin and subcutaneous tissue
XIII M00–M99 Diseases of the musculoskeletal system and connective tissue
XIV N00–N99 Diseases of the genitourinary system
XV O00–O99 Pregnancy, childbirth and the puerperium
XVI P00–P96 Certain conditions originating in the perinatal period
XVII Q00–Q99 Congenital malformations, deformations and chromosomal abnormalities
XVIII R00–R99 Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
XIX S00–T98 Injury, poisoning and certain other consequences of external causes
XX V01–Y98 External causes of morbidity and mortality
XXI Z00–Z99 Factors influencing health status and contact with health services
XXII U00–U99 Codes for special purposes
The International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) is a coding of diseases and signs, symptoms, abnormal findings, complaints, social circumstances and external causes of injury or diseases, as classified by the World Health Organization (WHO).[1] This page contains ICD-10 Chapter IV: Endocrine, nutritional and metabolic diseases.

This is an overview about the chapter IV (also called chapter E) of the International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10). This chapter is about Endocrine, nutritional and metabolic diseases.[2]

The ICD-10 is a coding of diseases and signs, symptoms, abnormal findings, complaints, social circumstances and external causes of injury or diseases, as classified by the World Health Organization (WHO). The code set allows more than 155,000 different codes and permits tracking of many new diagnoses and procedures, a significant expansion on the 17,000 codes available in ICD-9.[3]

E00–E35 – Endocrine diseases

(E00–E07) Thyroid gland / Thyroid hormone

(E10–E16) Pancreas / Insulin, glucagon

(E10–E14) Diabetes mellitus

(E15–E16) Other disorders of glucose regulation and pancreatic internal secretion

  • (E15) Nondiabetic hypoglycaemic coma
      • Drug-induced insulin coma in nondiabetic
      • Hyperinsulinism with hypoglycaemic coma
      • Hypoglycaemic coma NOS
  • (E16) Other disorders of pancreatic internal secretion
    • (E16.0) Drug-induced hypoglycaemia without coma
    • (E16.1) Other hypoglycaemia
      • Functional nonhyperinsulinaemic hypoglycaemia
      • Hyperinsulinism: NOS
      • Hyperinsulinism: functional
      • Hyperplasia of pancreatic islet beta cells NOS
      • Posthypoglycaemic coma encephalopathy
    • (E16.2) Hypoglycaemia, unspecified
    • (E16.3) Increased secretion of glucagon
    • (E16.4) Abnormal secretion of gastrin
      • Hypergastrinaemia
      • Zollinger-Ellison syndrome
    • (E16.8) Other specified disorders of pancreatic internal secretion
    • (E16.9) Disorder of pancreatic internal secretion, unspecified

(E20–E21) Parathyroid gland / PTH

(E22–E23) Pituitary gland / ADH, oxytocin, GH, ACTH, TSH, LH, FSH, prolactin

(E24–E27) Adrenal gland / Aldosterone, cortisol, epinephrine, norepinephrine

(E28–E30) Gonads / Estrogen, androgens, testosterone, etc.

(E31–E35) Other

  • (E31) Polyglandular dysfunction
    • (E31.0) Autoimmune polyglandular failure
      • Schmidt's syndrome
    • (E31.1) Polyglandular hyperfunction
  • (E32) Diseases of thymus
  • (E34) Other endocrine disorders
  • (E35) Disorders of endocrine glands in diseases classified elsewhere
    • (E35.0) Disorders of thyroid gland in diseases classified elsewhere
    • (E35.1) Disorders of adrenal glands in diseases classified elsewhere
    • (E35.8) Disorders of other endocrine glands in diseases classified elsewhere

E40–E68 – Nutritional diseases

(E40–E46) Malnutrition

  • (E40) Kwashiorkor
  • (E41) Nutritional marasmus
  • (E42) Marasmic kwashiorkor
  • (E43) Unspecified severe protein-energy malnutrition
  • (E44) Protein-energy malnutrition of moderate and mild degree
  • (E45) Retarded development following protein-energy malnutrition
  • (E46) Unspecified protein-energy malnutrition

(E50–E64) Other nutritional deficiencies

(E65–E68) Obesity and other hyperalimentation

E70–E90 – Metabolic diseases

(E70–E79) Metabolic disorders of proteins, fats, and carbohydrates

(E70–E72) Amino-acids

(E73–E74) Carbohydrates

(E75) Lipids

(E76–E78) Combinations

(E79–E90) Other metabolic disorders

See also

References

  1. ↑ WHO | International Classification of Diseases (ICD)
  2. ↑ http://apps.who.int/classifications/apps/icd/icd10online/?ge65.htm+e66
  3. ↑ CMS Office of Public Affairs (August 15, 2008). "HHS Proposes Adoption of ICD-10 Code Sets and Updated Electronic Transaction Standards" (web). News Release. U.S. Department of Health & Human Services. Retrieved 2008-10-22. 
Pathology: Medical conditions and ICD code
(Disease / Disorder / Syndrome / Sequence, Symptom / Sign, Injury, etc.)
(A/B, 001–139)
(C/D,
140–239 &
279–289)
Cancer (C00–D48, 140–239)
Myeloid hematologic (D50–D77, 280–289)
Lymphoid immune (D80–D89, 279)
(E, 240–278)
(F, 290–319)
(G, 320–359)
(H, 360–389)
(I, 390–459)
(J, 460–519)
(K, 520–579)
(L, 680–709)
(M, 710–739)
(N, 580–629)
(O, 630–679)
(P, 760–779)
(Q, 740–759)
(R, 780–799)
(S/T, 800–999)
Nutrition disorders (E40–E68, 260–269)
Hypoalimentation/
malnutrition
Protein-energy
malnutrition
Avitaminosis
B vitamins
Other
vitamins
Mineral
deficiency
Hyperalimentation
Overweight
Vitamin poisoning
Mineral overload

M: NUT

cof, enz, met

noco, nuvi, sysi/epon, met

drug (A8/11/12)

Inborn error of amino acid metabolism (E70–E72, 270)
K→acetyl-CoA
Lysine/straight chain
G
G→pyruvate→citrate
G→glutamate→
α-ketoglutarate
Glutamate/glutamine
General BC/OA
G→fumarate
Transport/
IE of RTT
Other

M: MET

mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m

k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon

m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)

Synthesis
Degradation
Acyl transport
Beta oxidation
General
Unsaturated
Odd chain
Other
To acetyl-CoA
Aldehyde

M: MET

mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m

k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon

m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)

Inborn error of carbohydrate metabolism: monosaccharide metabolism disorders (including glycogen storage diseases) (E73–E74, 271)
Sucrose, transport
(extracellular)
Disaccharide catabolism
Monosaccharide transport
Hexose → glucose
Monosaccharide catabolism
Glucose ⇄ glycogen
extralysosomal:
Glucose ⇄ CAC
Pentose phosphate pathway
Other

M: MET

mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m

k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon

m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)

Sphingolipidoses
(to ceramide)
NCL
Other

M: MET

mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m

k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon

m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)

Anabolism
Catabolism

M: MET

mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m

k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon

m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)

Anabolism
Post-translational modification
of lysosomal enzymes
Catabolism
Other

M: MET

mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m

k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon

m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)

Inborn error of lipid metabolism: dyslipidemia (E78, 272.0–272.6)
Hyperlipidemia
Hypolipoproteinemia
Lipodystrophy
Other

M: MET

mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m

k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon

m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)

Inborn error of purine-pyrimidine metabolism (E79, 277.2)
Purine metabolism
Anabolism
Catabolism
Pyrimidine metabolism
Anabolism
Catabolism

M: MET

mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m

k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon

m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)

Heme metabolism disorders (E80, 277.1, 277.4)
Porphyria,
hepatic and erythropoietic
(porphyrin)
early mitochondrial:
cytoplasmic:
late mitochondrial:
Hereditary hyperbilirubinemia
(bilirubin)
unconjugated:
conjugated:

M: MET

mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m

k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon

m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)

M: MYL

cell/phys (coag, heme, immu, gran), csfs

rbmg/mogr/tumr/hist, sysi/epon, btst

drug (B1/2/3+5+6), btst, trns

Genetic disorder, organelle: Peroxisomal disorders and lysosomal structural disorders (E80.3, 277.86)
Peroxisome biogenesis disorder
Enzyme-related
Transporter-related
Lysosomal
See also: proteins, intermediates
  • B structural
    • perx
    • skel
    • cili
    • mito
    • nucl
    • sclr
  • DNA/RNA/protein synthesis
    • drep
    • trfc
    • tscr
    • tltn
  • membrane
    • icha
    • slcr
    • atpa
    • abct
    • othr
  • transduction
    • iter
    • csrc
    • itra
  • trfk
Transition metal
Fe
high:
deficiency:
Cu
high:
deficiency:
Zn
high:
deficiency:
Electrolyte
Na+ and K+
  • see Template:Water-electrolyte imbalance and acid-base imbalance
PO43−
high:
deficiency:
Mg2+
high:
deficiency:
Ca2+
high:
deficiency:

M: NUT

cof, enz, met

noco, nuvi, sysi/epon, met

drug (A8/11/12)

Common amyloid forming proteins
Systemic amyloidosis
Organ-limited amyloidosis
Water-electrolyte imbalance and acid-base imbalance (E86–E87, 276)
Volume status
Electrolyte
Na+
K+
Cl−
Ca++
Acid-base
Acidosis
Alkalosis
Both
  • Mixed disorder of acid-base balance

M: URI

anat/phys/devp/cell

noco/acba/cong/tumr, sysi/epon, urte

proc/itvp, drug (G4B), blte, urte

Other metabolic pathology / Inborn error of metabolism (E70–E90, 270–279)
Other
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.